Clinical Trials Browser

Phase 1/2 × Rare Malignant Neoplasm × 90 days × Clear all

NCT07307053 2025-12-29

Rare Tumor Focused Platform Study of Innovative Therapies and Technologies (PLATFORM2)

Phase 1/2 Not yet recruiting

Other neoplasmOther solid neoplasm

Rare Malignant Neoplasm